Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2031 of 6351
-
New MRI dye could spot prostate cancer more clearly
Diagnosis OngoingThis trial examines if a prostate magnetic resonance spectroscopic imaging can be performed on a 3T scanner using an investigational contrast called hyperpolarized 13-C pyruvate for the development of a clinical prostate cancer exam. 3T refers to the strength of the magnetic reso…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Could a blood pressure drug curb alcohol cravings?
Disease control Recruiting nowThe goal of this research is to replicate findings previously conducted in a pilot trial and to understand, mechanistically, the role of stress in the development of AUD pharmacotherapies that target noradrenergic blockade.
Phase 2 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
French registry to track Real-World CAR-T outcomes in 5,000 patients
Knowledge-focused Recruiting nowThis study is a registry including prospective and retrospective data on all patients who have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell treatment.
Sponsor: The Lymphoma Academic Research Organisation • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New bone graft study aims to improve spine surgery outcomes
Disease control OngoingThis is a global, multi-center, prospective, randomized, blinded, controlled pivotal study. Clinical and radiological evaluation will be performed preoperatively and postoperatively up to 24 months; and endpoint success will be determined at 24 months postoperatively. Overall a …
Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo therapy shows promise in early myeloma trial
Disease control OngoingThis study will evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of belantamab mafodotin in combination with Velcade (bortezomib), Revlimid (lenalidomide), dexamethasone (VRd) and will determine recommended phase 3 dose (RP3D) in adult participants wi…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Pompe disease drug combo shows Long-Term safety in phase 3 trial
Disease control CompletedThis is a multicenter, international open-label extension study of ATB200/AT2221 in adult subjects with late-onset Pompe disease (LOPD) who completed Study ATB200-03.
Phase 3 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Blood test may replace anesthesia for heart valve fix
Diagnosis Recruiting nowParavalvular regurgitation (PVR) is an important complication of Transcatheter Aortic Valve Implantation (TAVI) that is associated with a 2.5-fold increase risk of mortality. Transesophageal echocardiographic (TEE) is considered as the gold standard to assess the severity of PVR …
Sponsor: University Hospital, Lille • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Promising prostate cancer drug apalutamide tested in chinese patients
Disease control CompletedThe purpose of this study is to compare the improvement in time to prostate specific antigen (PSA) progression (TTPP, as defined by Prostate Cancer Working Group 2 \[PCWG2\]) of apalutamide versus placebo in Chinese participants with high-risk non-metastatic castration resistant …
Phase 4 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New pill shows promise for rare bone marrow cancer
Disease control Recruiting nowThis study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or high-risk primary or secondary MF.
Phase 1/2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
A simple tool might empower dementia caregivers – but does it work?
Symptom relief CompletedCaregivers of home-dwelling people with Alzheimer's Disease and related dementias (ADRD) are one of the most rapidly growing populations in the United States. Among ADRD caregivers with unmet health-related social needs, this study aims to evaluate the effects of the CRx-D interv…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New drug targets Cancer's fuel supply in rare genetic tumors
Disease control OngoingThis phase II trial studies how well glutaminase inhibitor telaglenastat hydrochloride (CB-839 HCl) works in treating patients with specific genetic mutations and solid tumors or malignant peripheral nerve sheath tumors that have spread to other places in the body (metastatic) or…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Should heart bypass patients get blood thinners for new atrial fibrillation? major trial aims to find out
Disease control Recruiting nowThe primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POA…
Phase 3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New implant could help control bladder leaks without daily pills
Disease control OngoingProspective, multi-center, single-arm, seamless phase-pivotal study conducted in participants diagnosed with UUI who have failed or could not tolerate more conservative treatment. The trial will be conducted in two phases. Objective of Phase I: To assess the utilization of the s…
Sponsor: Neuspera Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a simple mesh stop painful hernias after surgery?
Prevention OngoingThis trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surge…
Sponsor: C. R. Bard • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Stem cells could offer new hope for severe eczema sufferers
Disease control OngoingA Multicenter, Randomized, Single-Blind, Phase Ⅱ Clinical Trial and Open Label Long-term Observation Study of ADSTEM Inj. to Evaluate the Safety and Efficacy in Patients with Moderate to Severe Subacute and Chronic Atopic Dermatitis. The aim of this study is to evaluate the safe…
Phase 2 • Sponsor: EHL Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple blood test predict pancreatic cancer before it strikes?
Knowledge-focused OngoingThis study is designed to develop a cohort of individuals without pancreatic cancer, but who are at increased risk of developing it due to family history or genetic predisposition. These high-risk individuals will be asked to provide baseline and annual (serial) follow-up blood s…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New PET scan tracer could light up hidden lung cancers
Diagnosis Recruiting nowThe purpose of this study is to look at how safe 89Zr-DFO-SC16.56 is, and how it is processed by the body in people with small cell lung cancer.
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Nerve surgery offers new hope for silent breathing struggle
Disease control Recruiting nowThis is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Walking analysis may save diabetic feet from ulcers and amputation
Disease control Recruiting nowDetermining whether the utilization of Noraxon myoRESEARCH Software gait analysis Evaluation and orthotic gait Correction can reduce diabetic foot ulceration Or subsequent amputation in patients with a history of a diabetic foot ulceration.
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for tough anemia: drug boosts blood cells in failed cases
Disease control CompletedThis was a non-randomized, open-label, phase II study to assess the efficacy and safety of eltrombopag in Chinese subjects with refractory or relapsed severe aplastic anemia (SAA). Treatment with eltrombopag was started at 25 mg/day and increased by 25 mg/day every 2 weeks accord…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC